Journal profile · Medicine-Oncology
Forum of Clinical Oncology
ISSN 1792-345X · eISSN 1792-362X · Hellenic Society of Medical Oncology (He.S.M.O.) · Poland
Forum of Clinical Oncology: fully open access; no APC; review about 6 weeks (community reports); 10 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Forum of Clinical Oncology is published by Hellenic Society of Medical Oncology (He.S.M.O.). By OpenAlex counts of its recent articles, its largest topics are Breast Cancer Treatment Studies, Cancer Immunotherapy and Biomarkers and Lung Cancer Diagnosis and Treatment, together about 24.1% of its articles. Its main subfields are Oncology and Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Why subscribe and readWe would like to present to you the Forum of Clinical Oncology (FCO), the official scientific journal of the Hellenic Society of Medical Oncology.In the Hellenic Society of Medical Oncology we want FCO to serve as a forum, for us all, to communicate clinical and research achievements in English; to share thoughts, opinions, facts, problems and solutions.We envision the journal to be the means, by which our efforts in the fight against cancer will become known to a wider audience, thus establishing our presence in the global setting. FCO publishes original and translational research articles relevant to diagnosis and treatment of cancer, state-of-the-art reviews, case reports, research articles, statements of opinion and comments, all related to clinical practice and basic research. A large number of eminent Greek and Foreign colleagues who participate in the National and International Editorial Boards, with their continuum direction and support, guarantee the high quality of the work published in FCO. In every issue published there will be something new, enjoyable and exciting to be read.Why submitWe would like to welcome you to the Forum of Clinical Oncology (FCO), the official scientific journal of the Hellenic Society of Medical Oncology.In the Hellenic Society of Medical Oncology we share the view that there are many issues we deal with in our everyday clinical and research practice that are common to our colleagues geographically closer to us, in the Balkans and the Mediterranean basin, but also to those in other parts of the world. That led us to dare "the great leap forward": to broaden the scope of our Greek scientific journal for oncology, published in Greek for the last 10 years, and develop Forum of Clinical Oncology a web based open access journal in English.FCO will serve as a forum for us all to communicate clinical and research achievements. One of the innovations of the journal is its online management from submission of an article to its publication. Online is more efficient: submitting, reviewing, proofreading, filing and indexing. However, the most important benefit of all is easy universal access.English has become the common language amongst scientists from around the globe. This is the reason why we chose English as the official language of the journal. Many Greek colleagues have already published work in English in distinguished journals or have studied or worked abroad. We believe that the language change will
From the journal's Aims & Scope
Research area (LetPub): Medicine-Oncology
Editor-in-chief Nikolaos TsoukalasPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology11.6%
- Cancer Immunotherapy and BiomarkersMedicine6.5%
- Lung Cancer Diagnosis and TreatmentMedicine6%
- Breast Lesions and CarcinomasMedicine6%
- Lung Cancer Treatments and MutationsMedicine5.5%
- Head and Neck Cancer StudiesMedicine5%
- Colorectal Cancer Treatments and StudiesMedicine5%
- Colorectal Cancer Surgical TreatmentsMedicine4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Oncology | Q4 | 394/428 | 8th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 0.3LetPub ·
- CiteScore (publisher)
- 0.3Publisher website ·
- SJR 2026-06
- 0.12LetPub ·
- SNIP 2026-06
- 0.09LetPub ·
- h-index
- 7OpenAlex ·
- i10-index
- 3OpenAlex ·
- 2-year mean citedness
- 0.34OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 169 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 12 | 12 | 29 |
| 2025 | 10 | 10 | 36 |
| 2024 | 13 | 13 | 25 |
| 2023 | 23 | 23 | 25 |
| 2022 | 22 | 22 | 25 |
| 2021 | 23 | 23 | 32 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 6 weeksLetPub ·
- Peer review
- Peer reviewLetPub
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| LetPub | No APC | No | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteLicense & copyright
- License & copyright Copyright 2026 © Paradigm. All rights reserved.
Currency:EUR €USD $GBP £ Terms of servicePrivacy policyEthical policiesAccessibility
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Hellenic Society of Medical Oncology (He.S.M.O.)
- Country or region
- Poland
- Language
- English
- ISSN
- 1792-345X
- Electronic ISSN
- 1792-362X
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about Forum of Clinical Oncology
How long does peer review take at Forum of Clinical Oncology?
Authors report an average review time of about 6 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Forum of Clinical Oncology?
According to LetPub and DOAJ records, Forum of Clinical Oncology is indexed in Scopus and DOAJ.
Is Forum of Clinical Oncology open access, and what is the APC?
Forum of Clinical Oncology is a fully open-access journal. It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-28). Last updated: .